Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 18, Issue 1, 2013, Pages

  Gómez Moreno, Gerardo ^a   Guardia, Javier ^a   Aguilar Salvatierra, Antonio ^a   Cabrera Ayala, Maribel ^a   de Val, José Eduardo Maté Sánchez ^b   Calvo Guirado, José Luis ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Antihypertensive drugs; Hyposialia; Malic acid; Xerostomia

Indexed keywords

ANTIHYPERTENSIVE AGENT; FLUORIDE; MALIC ACID; PLACEBO; UNCLASSIFIED DRUG; XEROS DENTAID; XYLITOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SCORING SYSTEM; TREATMENT OUTCOME; XEROSTOMIA;

ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALATES; MALE; MIDDLE AGED; QUESTIONNAIRES; XEROSTOMIA;

EID: 84871862845     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.18206     Document Type: Article

References (26)

1. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003;20:64-77.
2. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivaly gland hypofunction. J Dent Res. 1992;71:1363-9.
3. Mittal S, Bansal V, Garg S, Atreja G, Bansal S. The diagnostic role of Saliva -A Review. J Clin Exp Dent. 2011;3:e314-20.
4. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987;66:648-53.
5. Wolff MS, Kleinberg I. The effect of ammonium glycopyrrolate (Robinul)-induced xerostomia on oral mucosal wetness and flow of gingival crevicular fluid in humans. Arch Oral Biol. 1999;44:97-102.
6. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72:841-6.
7. Silvestre-Donat FJ, Miralles-Jorda L, Martinez-Mihi V. Protocol for the clinical management of dry mouth. Med Oral. 2004;9:273-9.
8. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004;15:221-39.
9. Martín-Piedra MA, Gómez-Moreno G, Herrera D, Aguilar-Salvatierra A. Effectiveness of a recent topical sialogogue in the management of drug-induced xerostomia. J Clin Exp Dent. 2011;3:e268-73.
10. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res. 2000;79:1652-8.
11. Murray Thomson W, Chalmers JM, John Spencer A, Slade GD, Carter KD. A longitudinal study of medication exposure and xerostomia among older people. Gerodontology. 2006;23:205-13.
12. de Almeida Pdel V, Grégio AM, Brancher JA, Ignácio SA, Machado MA, de Lima AA, et al. Effects of antidepressants and benzodiazepines on stimulated salivary flow rate and biochemistry composition of the saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:58-65.
13. Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16:12-7.
14. Locker D. Subjective reports of oral dryness in an older adult population. Community Dent Oral Epidemiol. 1993;21:165-8.
15. Narhi TO. Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res. 1994;73:20-5.
16. Anneroth G, Nordenram G, Bengtsson S. Effect of saliva stimulants (Hybrin and malic acid) on cervical root surfaces in vitro. Scand J Dent Res. 1980;88:214-8.
17. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000;14:197-203.
18. da Mata AD, da Silva Marques DN, Silveira JM, Marques JR, de Melo Campos Felino ET, Guilherme NF. Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial. Oral Dis. 2009;15:220-8.
19. Vissink A, Schaub RM, van Rijn LJ, Gravenmade EJ, Panders AK, Vermey A. The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia. Gerodontology. 1987;6:95-101.
20. Gravenmade EJ, Vissink A. Mucin-containing lozenges in the treatment of intraoral problems associated with Sjögren's syndrome. A double-blind crossover study in 42 patients. Oral Surg Oral Med Oral Pathol. 1993;75:466-71.
21. van der Reijden WA, van der Kwaak H, Vissink A, Veerman EC, Amerongen AV. Treatment of xerostomia with polymer-based salivae55 substitutes in patients with Sjögren's syndrome. Arthritis Rheum. 1996;39:57-63.
22. Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int. 1998;29:383-8.
23. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res. 1982;61:1158-62.
24. Gambon DL, Brand HS, Nieuw Amerongen AV. The erosive potential of candy sprays. Br Dent J. 2009;206:530-1.
25. Chunmuang S, Jitpukdeebodintra S, Chuenarrom C, Benjakul P. Effect of xylitol and fluoride on enamel erosion in vitro. J Oral Sci. 2007;49:293-7.
26. Hove LH, Holme B, Young A, Tveit AB. The protective effect of TiF4, SnF2 and NaF against erosion-like lesions in situ. Caries Res. 2008;42:68-72.